Follow The Follow-On Money: Obama’s Budget Has Modest Biogeneric Savings

The fiscal 2010 federal budget outlined by the Obama administration Feb. 25 takes a conservative view of the fiscal benefit of generic biologics - estimating they will contribute $9.2 billion over 10 years to help pay for health care reform